Stealth BioTherapeutics, Inc.

Stealth BioTherapeutics, Inc., is a clinical stage, biopharmaceutical company developing novel mitochondrial targeted therapies for diseases with clear unmet medical needs including cardiovascular, renal and metabolic diseases. The company’s first clinical candidate, Bendaviaâ„¢, targets the mitochondria to treat cardio-renal and microvascular impairments.

Phytex, LLC

Phytex, LLC, produces phytase enzymes for an animal feed product called OptiPhos. This product enables poultry and pigs to absorb more phosphorus from their feed grain, creating substantially less phosphorus in their waste. Phytex was acquired by Huvepharma in 2013.

GeneWeave Biosciences, Inc.

GeneWeave Biosciences, Inc., is a medical diagnostics company focused on infectious diseases. GeneWeave was acquired by Roche Holding AG in 2015.

Acuamark Diagnostics, Inc.

Acuamark Diagnostics is developing novel diagnostic tests to enable low-cost and accurate early detection of colorectal cancer directly from the blood, by isolating and identifying multiple cancer markers. Thus, allowing for improved sensitivity, specificity, and scalability.